JNK Cancer Research Results

JNK, c-Jun N-terminal kinase (JNK): Click to Expand ⟱
Source:
Type:
JNK acts synergistically with NF-κB, JAK/STAT, and other signaling molecules to exert a survival function. Janus signaling promotes cancer cell survival.
JNK, or c-Jun N-terminal kinase, is a member of the mitogen-activated protein kinase (MAPK) family. It plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis (programmed cell death). JNK is activated in response to various stress signals, such as UV radiation, oxidative stress, and inflammatory cytokines.
JNK activation can promote apoptosis in cancer cells, acting as a tumor suppressor. However, in other contexts, it can promote cell survival and proliferation, contributing to tumor progression.

JNK is often unregulated in cancers, leading to increased cancer cell proliferation, survival, and resistance to apoptosis. This activation is typically associated with poor prognosis and aggressive tumor behavior.


Scientific Papers found: Click to Expand⟱
3079- RES,    Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action
- Review, Var, NA
angioG↓, TumMeta↓, ChemoSen↑, NADPH↑, SIRT1↑, NF-kB↓, NLRP3↓, Dose↝, COX2/PTGS2↓, MMP9↓, PGE2↓, TIMP1↑, TIMP2↑, Sp1/3/4↓, p‑JNK↓, uPAR↓, ROS↓, CXCR4↓, IL6↓, Gli1↓, *ROS↓, *GSTs↑, *SOD↑, *Catalase↑, *GPx↑, *lipid-P↓, *GSH↑, Synergy↑, Synergy↑, Synergy↑,
3077- RES,    Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways
- in-vitro, Chon, HTB94
MMP2↓, MMP9↓, SOX9↑, MMPs↓, p‑p38↑, p‑JNK↓, NF-kB↓, HO-1↓,
1744- RosA,    Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity
- Review, Var, NA
chemoR↓, ChemoSideEff↓, RadioS↑, ROS↓, ChemoSen↑, BioAv↑, Half-Life↝, antiOx↑, ROS↑, Fenton↑, DNAdam↑, Apoptosis↑, CSCs↓, HH↓, Bax:Bcl2↑, MDR1↓, P-gp/ABCB1↓, Synergy↑, eff↑, FOXO4↑, *eff↑, *ROS↓, *JNK↓, *ERK↓, *GSH↑, *H2O2↑, *MDA↓, *SOD↑, *HO-1↑, *CardioT↓, selectivity↑,
3017- RosA,  Per,    Molecular Mechanism of Antioxidant and Anti-Inflammatory Effects of Omega-3 Fatty Acids in Perilla Seed Oil and Rosmarinic Acid Rich Fraction Extracted from Perilla Seed Meal on TNF-α Induced A549 Lung Adenocarcinoma Cells
- in-vitro, Lung, A549
TumCD∅, ROS↓, IL1β↓, IL6↓, IL8↓, TNF-α↓, COX2/PTGS2↓, SOD2↓, FOXO1↓, NF-kB↓, JNK↓, antiOx↑, tumCV∅,
3021- RosA,    Rosmarinic acid ameliorates septic-associated mortality and lung injury in mice via GRP78/IRE1α/JNK pathway
- in-vivo, Sepsis, NA
*eff↑, *SOD↑, *MDA↓, *GRP78/BiP↓, *IRE1↓, *JNK↓, *Sepsis↓,
3023- RosA,    Rosmarinic acid alleviates septic acute respiratory distress syndrome in mice by suppressing the bronchial epithelial RAS-mediated ferroptosis
- in-vivo, Sepsis, NA
*GPx4↑, *Inflam↓, *ER Stress↓, *Ferroptosis↓, *Sepsis↓, *GRP78/BiP↓, *IRE1↓, JNK↓,
3001- RosA,    Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review
- Review, Var, NA
TumCP↓, Apoptosis↑, TumMeta↓, Inflam↓, *antiOx↑, *AntiAge↑, *ROS↓, BioAv↑, Dose↝, NRF2↑, P-gp/ABCB1↑, ATP↑, MMPs↓, cl‑PARP↓, Hif1a↓, GlucoseCon↓, lactateProd↓, Warburg↓, TNF-α↓, COX2/PTGS2↓, IL6↓, HDAC2↓, GSH↑, ROS↓, ChemoSen↑, *BG↓, *IL1β↓, *TNF-α↓, *IL6↓, *p‑JNK↓, *p38↓, *Catalase↑, *SOD↑, *GSTs↑, *VitC↑, *VitE↑, *GSH↑, *GutMicro↑, *cardioP↑, *ROS↓, *MMP↓, *lipid-P↓, *NRF2↑, *hepatoP↑, *neuroP↑, *P450↑, *HO-1↑, *AntiAge↑, *motorD↓,
7951- RT,  BuckWS,    The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives
- Review, Nor, NA
*Dose↝, *BioAv↓, *BioAv↓, *BioAv↓, *BioAv↓, *BioAv↝, TumCP↓, Risk↓, *radioP↑, chemoPv↑, TumCCA↑, GSK‐3β↑, Wnt↓, β-catenin/ZEB1↓, ROS↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, PARP↑, Beclin-1/ATG6↑, ATG5↑, LC3II↑, DNMT1↓, P21↑, CDK1↑, CycB/CCNB1↓, TNF-α↑, VEGF↓, IL1β↓, NF-kB↓, AP-1↓, MYCN↓, AMPK↑, MAPK↓, PI3K↓, Akt↓, cMET↓, P-gp/ABCB1↓, MRP1/ABCC1↓, ABCG2↓, MMPs↓, TNF-α↓, iNOS↓, COX2/PTGS2↓, angioG↓, STAT3↓, *chemoP↑, *ROS↓, *MDA↓, *P53↓, *Casp3↓, *Casp9↓, *JNK↓, *TNF-α↓, *p38↓, *MAPK↓, GSH↓, ChemoSen↑, *hepatoP↑, *COX1↓, *COX2/PTGS2↓, *15-LOX/ALOX15↓, RenoP↑, *toxicity↓,
5003- Sal,    Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review
- Review, Var, NA
CSCs↓, TumAuto↑, selectivity↑, DNAdam↑, TumCCA↑, P-gp/ABCB1↓, Wnt↓, β-catenin/ZEB1↓, RadioS↑, ChemoSen↑, Shh↓, eff↓, ROS↑, AMPK↑, JNK↑, ER Stress↑,
3315- SIL,    Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats
- in-vivo, Nor, NA
neuroP↑, *NRF2↑, *HO-1↑, *lipid-P↓, *GSH↑, *SOD↑, *Catalase↑, *GPx↑, *NF-kB↓, *TNF-α↓, *JNK↓, *Bcl-2↑, *BAX↑,
3304- SIL,    Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells
- in-vitro, GC, AGS - in-vivo, NA, NA
BAX↑, p‑JNK↑, p‑p38↑, cl‑PARP↑, Bcl-2↓, p‑ERK↓, TumVol↓, Apoptosis↑, tumCV↓,
3305- SIL,    Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vivo, NA, NA
TumCP↓, tumCV↓, BAX↑, cl‑PARP↑, Casp9↑, p‑JNK↑, Bcl-2↓, p‑p38↓, p‑ERK↓, *toxicity∅, Dose↝, *hepatoP↑, Inflam↓, AntiCan↑,
3301- SIL,    Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid
- Review, Var, NA
Inflam↓, TumCCA↑, Apoptosis↓, TumMeta↓, TumCG↓, angioG↓, chemoP↑, radioP↑, p‑ERK↓, p‑p38↓, p‑JNK↓, P53↑, Bcl-2↓, Bcl-xL↓, TGF-β↓, MMP2↓, MMP9↓, E-cadherin↑, Wnt↓, Vim↓, VEGF↓, IL6↓, STAT3↓, *ROS↓, IL1β↓, PGE2↓, CDK1↓, CycB/CCNB1↓, survivin↓, Mcl-1↓, Casp3↑, Casp9↑, cMyc↓, COX2/PTGS2↓, Hif1a↓, CXCR4↓, CSCs↓, EMT↓, N-cadherin↓, PCNA↓, cycD1/CCND1↓, ROS↑, Synergy↑, Synergy↑, Synergy↑, HER2/EBBR2↓,
3296- SIL,    Silibinin induces oral cancer cell apoptosis and reactive oxygen species generation by activating the JNK/c-Jun pathway
- in-vitro, Oral, Ca9-22 - in-vivo, Oral, YD10B
TumCP↓, TumCCA↑, ROS↑, SOD1↓, SOD2↓, *JNK↑, toxicity?, TumCMig↓, TumCI↓, N-cadherin↓, Vim↓, E-cadherin↑, EMT↓, P53↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, Bcl-2↓, SOD↓,
3293- SIL,    Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
- Review, Var, NA
hepatoP↑, TumMeta↓, Inflam↓, chemoP↑, radioP↑, Half-Life↝, *GSTs↑, p‑JNK↑, BAX↑, p‑p38↑, cl‑PARP↑, Bcl-2↓, p‑ERK↓, TumVol↓, Synergy↑, TumCCA↑, STAT3↓, Mcl-1↓, survivin↓, Bcl-xL↓, Casp3↑, Casp9↑, eff↑, CXCR4↓, Dose↝,
3319- SIL,    Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
- Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *ROS↓, *Inflam↓, *Apoptosis↓, *BBB?, *tau↓, *NF-kB↓, *IL1β↓, *TNF-α↓, *IL4↓, *MAPK↓, *memory↑, *cognitive↑, *Aβ↓, *ROS↓, *lipid-P↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *AChE↓, *BChE↓, *p‑ERK↓, *p‑JNK↓, *p‑p38↓, *GutMicro↑, *COX2/PTGS2↓, *iNOS↓, *TLR4↓, *neuroP↑, *Strength↑, *AMPK↑, *MMP↑, *necrosis↓, *NRF2↑, *HO-1↑,
2355- SK,    Pharmacological properties and derivatives of shikonin-A review in recent years
- Review, Var, NA
AntiCan↑, TumCP↓, TumCMig↓, Apoptosis↑, TumAuto↑, Necroptosis↑, ROS↑, TrxR1↓, PKM2↓, RIP1↓, RIP3↓, Src↓, FAK↓, PI3K↓, Akt↓, mTOR↓, GRP58↓, MMPs↓, ATF2↓, cl‑PARP↑, Casp3↑, p‑p38↑, p‑JNK↑, p‑ERK↓,
2231- SK,    Shikonin Exerts Cytotoxic Effects in Human Colon Cancers by Inducing Apoptotic Cell Death via the Endoplasmic Reticulum and Mitochondria-Mediated Pathways
- in-vitro, CRC, SNU-407
Apoptosis↑, ER Stress↑, PERK↑, eIF2α↑, CHOP/DDIT3↑, mt-Ca+2↑, MMP↓, Bcl-2↓, Casp3↑, Casp9↑, ERK↑, JNK↑, p38↓,
2196- SK,    Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species
- Review, Var, NA
*ALAT↓, *AST↓, *Inflam?, *EMT↑, ROS?, TrxR1↓, PERK↑, eIF2α↑, ATF4↑, CHOP/DDIT3↑, IRE1↑, JNK↑, eff↝, DR5↑, Glycolysis↓, PKM2↓, ChemoSen↑, GPx4↓, HO-1↑,
2228- SK,    Shikonin induced Apoptosis Mediated by Endoplasmic Reticulum Stress in Colorectal Cancer Cells
- in-vitro, CRC, HCT116 - in-vitro, CRC, HCT15 - in-vivo, NA, NA
Apoptosis↑, Bcl-2↓, Casp3↑, Casp9↑, cl‑PARP↑, GRP78/BiP↑, PERK↑, eIF2α↑, ATF4↑, CHOP/DDIT3↑, JNK↑, eff↓, ER Stress↑, ROS↑, TumCG↓,
3042- SK,    The protective effects of Shikonin on lipopolysaccharide/D -galactosamine-induced acute liver injury via inhibiting MAPK and NF-kB and activating Nrf2/HO-1 signaling pathways
- in-vivo, Nor, NA
*TNF-α↓, *IL1β↓, *IL6↓, *IFN-γ↓, *ALAT↓, *AST↓, *MPO↓, *ROS↓, *JNK↓, *ERK↓, *p38↓, *NF-kB↓, *p‑IKKα↓, *SOD↑, *GSH↑, *HO-1↑, *NRF2↑, *hepatoP↑,
5102- SK,  GEM,    Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway
- vitro+vivo, PC, NA
TumCG↓, ChemoSen↑, NF-kB↓, PCNA↓, Ki-67↓, p‑EGFR↓, ROS↑, TumCCA↑, P53↑, JNK↑, Akt↓,
1195- SM,    Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways
- in-vitro, Lung, A549 - in-vitro, Liver, HepG2 - in-vitro, CRC, HCT116
T-Cell↑, TumCP∅, IL4↑, IL6↑, IFN-γ↑, TLR4↑, TLR1↑, TLR2↑, p‑JNK↑, p‑ERK↑, IKKα↑,
5333- TFdiG,    Theaflavin-3,3′-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts
- vitro+vivo, OS, MG63
tumCV↓, TumCP↓, TumCCA↑, Iron↑, ROS↑, GSH↓, Fenton↑, Ferroptosis↑, Apoptosis↑, MAPK↑, ERK↑, JNK↑, p38↑, TumCG↓, Dose↝, FTH1↓, GPx4↓,
2121- TQ,    Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
p‑p38↑, ROS↑, TumCP↓, ChemoSen↑, XIAP↓, survivin↓, Bcl-xL↓, Bcl-2↓, Ki-67↓, *Catalase↑, *SOD↑, *GSH↑, hepatoP↑, p‑MAPK↑, JNK↓, eff↓,
4173- TQ,    Thymoquinone Can Improve Neuronal Survival and Promote Neurogenesis in Rat Hippocampal Neurons
- in-vivo, Nor, NA
*neuroP↑, *Casp3↓, *Apoptosis↓, *ERK↑, *JNK↑, *CREB↑, *iNOS↑, *BDNF∅,
3397- TQ,    Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer
- Review, CRC, NA
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2/PTGS2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
3425- TQ,    Advances in research on the relationship between thymoquinone and pancreatic cancer
- in-vitro, PC, NA
Apoptosis↑, TumCP↓, TumCI↓, TumMeta↓, ChemoSen↑, angioG↓, Inflam↓, NF-kB↓, PI3K↓, Akt↓, TGF-β↓, Jun↓, p38↑, MAPK↑, MMP9↓, PKM2↓, ROS↑, JNK↑, MUC4↓, TGF-β↑, Dose↝, FAK↓, NOTCH↓, PTEN↑, mTOR↓, Warburg↓, XIAP↓, COX2/PTGS2↓, Casp9↑, Ki-67↓, CD34↓, VEGF↓, MCP1/CCL2↓, survivin↓, Cyt‑c↑, Casp3↑, H4↑, HDAC↓,
3427- TQ,    Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
- in-vitro, Var, NA
ROS⇅, Fas↑, DR5↑, TRAIL↑, Casp3↑, Casp8↑, Casp9↑, P53↑, mTOR↓, Bcl-2↓, BID↓, CXCR4↓, JNK↑, p38↑, MAPK↑, LC3II↑, ATG7↑, Beclin-1/ATG6↑, AMPK↑, PPARγ↑, eIF2α↓, P70S6K↓, VEGF↓, ERK↓, NF-kB↓, XIAP↓, survivin↓, p65↓, DLC1↑, FOXO↑, TET2↑, CYP1B1↑, UHRF1↓, DNMT1↓, HDAC1↓, IL2↑, IL1↓, IL6↓, IL10↓, IL12↓, TNF-α↓, iNOS↓, COX2/PTGS2↓, 5LO↓, AP-1↓, PI3K↓, Akt↓, cMET↓, VEGFR2/KDR/Flk1↓, CXCL1↓, ITGA5↓, Wnt↓, β-catenin/ZEB1↓, GSK‐3β↓, Myc↓, cycD1/CCND1↓, N-cadherin↓, Snail↓, Slug↓, Vim↓, Twist↓, Zeb1↓, MMP2↓, MMP7↓, MMP9↓, JAK2↓, STAT3↓, NOTCH↓, cycA1/CCNA1↓, CDK2↓, CDK4↓, CDK6↓, CDC2↓, CDC25↓, Mcl-1↓, E2Fs↓, p16↑, p27/CDKN1B↑, P21↑, ChemoSen↑,
3559- TQ,    Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
- Review, AD, NA - Review, Var, NA
*antiOx↑, *Inflam↓, *AChE↓, AntiCan↑, *cardioP↑, *RenoP↑, *neuroP↑, *hepatoP↑, TumCG↓, Apoptosis↑, PI3K↓, Akt↑, TumCCA↑, angioG↓, *NF-kB↓, *TLR2↓, *TLR4↓, *MyD88↓, *TRIF↓, *IRF3↓, *IL1β↓, *IL6↓, *IL12↓, *NRF2↑, *COX2/PTGS2↓, *VEGF↓, *MMP9↓, *cMyc↓, *cycD1/CCND1↓, *TumCP↓, *TumCI↓, *MDA↓, *TGF-β↓, *CRP↓, *Casp3↓, *GSH↑, *IL10↑, *iNOS↑, *lipid-P↓, *SOD↑, *H2O2↓, *ROS↓, *LDH↓, *Catalase↑, *GPx↑, *AChE↓, *cognitive↑, *MAPK↑, *JNK↑, *BAX↓, *memory↑, *Aβ↓, *MMP↑,
2411- UA,    Ursolic acid in health and disease
- Review, Var, NA
Inflam↓, antiOx↑, NF-kB↓, Bcl-xL↓, Bcl-2↓, cycD1/CCND1↓, Ki-67↓, CD31/PECAM-1↓, STAT3↓, EGFR↓, P53↑, P21↓, HK2↓, PKM2↓, ATP↓, lactateProd↓, p‑ERK↓, MMP↓, NO↑, ATM↑, Casp3↑, AMPK↑, JNK↑, FAO↑, FASN↓, *GSH↑, *SOD↑, *Catalase↑, *GPx↑, *GSTs↑, neuroP↑,
3107- VitC,    Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment
- Review, Var, NA
Risk↓, *ROS↓, ROS↑, VEGF↓, COX2/PTGS2↓, ER Stress↑, IRE1↑, JNK↑, CHOP/DDIT3↑, Hif1a↓, Synergy↑, Glycolysis↓, MMPs↓, TumMeta↓, YAP/TEAD↓, Synergy↑, TET1↑,
1818- VitK2,    New insights on vitamin K biology with relevance to cancer
- Review, Var, NA
TumCG↓, ChemoSen↑, toxicity∅, OS↑, BMD↑, eff↑, MMP↓, ROS↑, eff↓, ERK↑, JNK↑, p38↑, Cyt‑c↑, Casp↑, ATP↓, lactateProd↑, AMPK↑, Rho↓, TumCG↓, BioAv↑, cardioP↑, Risk↓,
2279- VitK2,    Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways
- in-vitro, Bladder, T24/HTB-9 - in-vitro, Bladder, J82 - in-vitro, Nor, HEK293 - in-vitro, Nor, L02 - in-vivo, NA, NA
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,
7916- VT,    Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway
- in-vitro, HCC, NA
*antiOx↑, *Inflam↓, *AntiTum↑, Apoptosis↑, Casp3↑, Bcl-2↓, LC3II↓, p‑JNK↑, p‑ERK↓,
9133- ZYF,    Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway
- in-vitro, PC, NA
TumCP↓, Apoptosis↑, TumCCA↑, ER Stress↑, TumAuto↑, JNK↑, Synergy↑, cl‑Casp3↑, cl‑PARP↑, p‑Akt↓, ERK↓, PERK↑, eIF2α↑, p‑IRE1↑, CHOP/DDIT3↑, AMPK↑,

Showing Research Papers: 201 to 236 of 236
Prev Page 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 236

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 4,   antiOx⇅, 1,   Catalase↓, 4,   Catalase↑, 1,   Fenton↑, 5,   GPx↓, 3,   GPx4↓, 4,   GSH↓, 16,   GSH↑, 1,   GSH/GSSG↓, 2,   GSR↓, 1,   GSTs↓, 1,   H2O2↑, 3,   HNE↑, 1,   HO-1↓, 5,   HO-1↑, 8,   Iron↓, 1,   Iron↑, 3,   i-Iron↑, 1,   lipid-P↓, 2,   lipid-P↑, 6,   lipid-P↝, 1,   MDA↓, 2,   MDA↑, 3,   MPO↓, 1,   NADH↓, 1,   NQO1↓, 1,   NQO1↑, 2,   NRF2↓, 10,   NRF2↑, 9,   NRF2↝, 1,   Prx↓, 1,   ROS?, 2,   ROS↓, 8,   ROS↑, 111,   ROS⇅, 3,   ROS↝, 1,   ROS∅, 1,   i-ROS↓, 1,   m-ROS↑, 1,   mt-ROS↑, 3,   SOD↓, 6,   SOD↑, 1,   SOD1↓, 2,   SOD2↓, 3,   Trx↓, 4,   Trx1↓, 2,   TrxR↓, 4,   TrxR1↓, 3,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 3,   CDC25↓, 4,   CDC25↑, 1,   compIII↓, 1,   CS↓, 1,   ETC↓, 2,   mitResp↓, 2,   mtDam↑, 5,   OXPHOS↓, 2,   PDH↓, 1,   PDH↑, 1,   PGC-1α↑, 1,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 2,   ACLY↓, 1,   ACSL4↑, 1,   ALDOA↓, 1,   ALDOB↑, 1,   AMPK↓, 1,   AMPK↑, 13,   ATP↓, 8,   ATP↑, 1,   CAIX/CA9↑, 1,   ENO1↓, 1,   ENO3↑, 1,   FAO↑, 1,   FASN↓, 4,   FBP1↑, 1,   G6PD↓, 1,   GAPDH↓, 1,   GLO-I↓, 1,   GlucoseCon↓, 6,   glut↓, 1,   GlutaM↓, 1,   Glycolysis↓, 10,   GSK‐3β↓, 5,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 4,   HK2↓, 5,   HK3↑, 1,   lactateProd↓, 7,   lactateProd↑, 1,   LDHA↓, 3,   MCT4↓, 1,   NADPH↓, 1,   NADPH↑, 2,   PCK1↑, 1,   p‑PDK1 / PDPK1↓, 1,   PFK↓, 1,   PFK1↓, 1,   PGK2↑, 1,   PGM1↑, 1,   PGM3↑, 1,   PKLR↑, 1,   PKM2↓, 6,   PKM2↑, 1,   p‑S6↓, 1,   SCD1↓, 1,   SIRT1↓, 3,   SIRT1↑, 2,   SREBP1/SREBF1↓, 1,   TCA↓, 1,   Warburg↓, 4,  

Cell Death(tgid=5) ⓘ

AIF↑, 9,   AIF↝, 1,   APAF1↑, 3,   Apoptosis?, 1,   Apoptosis↓, 1,   Apoptosis↑, 93,   Apoptosis↝, 1,   mt-Apoptosis↑, 2,   ASC↓, 1,   ASK1↑, 2,   BAD↑, 4,   BAX↑, 48,   BAX⇅, 1,   BAX↝, 1,   Bax:Bcl2↑, 9,   Bcl-2↓, 49,   Bcl-2↑, 2,   Bcl-2↝, 1,   cl‑Bcl-2↓, 1,   Bcl-xL↓, 13,   Bcl-xL↝, 1,   BID↓, 1,   BID↑, 3,   p‑BID↓, 1,   BNIP3↝, 1,   Casp↑, 13,   Casp1↓, 1,   Casp10↑, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 2,   Casp3↑, 67,   Casp3↝, 1,   cl‑Casp3↑, 13,   proCasp3↑, 1,   Casp6↑, 2,   Casp7↑, 4,   cl‑Casp7↑, 1,   Casp8↑, 20,   cl‑Casp8↑, 3,   Casp9↑, 46,   cl‑Casp9↑, 4,   cFLIP↓, 2,   Cyt‑c↓, 1,   Cyt‑c↑, 46,   Cyt‑c↝, 2,   Diablo↑, 3,   DR5↑, 16,   Endon↑, 2,   FADD↑, 1,   Fap1↓, 1,   Fas↓, 1,   Fas↑, 13,   FasL↓, 1,   FasL↑, 7,   Ferroptosis↑, 4,   GranB/GZMB↝, 1,   GRP58↓, 1,   GSDMD↑, 1,   IAP1↓, 3,   IAP2/BIRC3↓, 2,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 1,   iNOS↓, 8,   Mcl-1↓, 13,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 2,   MDM2↑, 1,   p‑MDM2↓, 1,   Necroptosis↑, 1,   p38↓, 7,   p38↑, 32,   p‑p38↓, 4,   p‑p38↑, 15,   p‑p38↝, 1,   Paraptosis↑, 1,   Perforin↝, 1,   PUMA↑, 1,   Pyro↑, 3,   RIP3↓, 1,   survivin↓, 24,   TRAIL↑, 2,   TumCD↑, 10,   TumCD∅, 1,   XIAP↓, 11,   YAP/TEAD↓, 2,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 57,   Akt↑, 2,   Akt↝, 2,   p‑Akt↓, 10,   p‑Akt↑, 2,   AKT1↓, 1,   Akt2↓, 1,   CK2↓, 2,   cMET↓, 2,   CREB↓, 1,   cSrc↓, 1,   DDIT4↑, 1,   EF-1α↓, 1,   EGFR↓, 11,   EGFR↑, 1,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 36,   ERK↑, 15,   ERK↝, 1,   p‑ERK↓, 17,   p‑ERK↑, 10,   p‑ERK⇅, 1,   p‑ERK↝, 1,   GRB2↓, 1,   HER2/EBBR2↓, 4,   HGF/c-Met↓, 1,   IGF-1R↓, 1,   IKKα↓, 2,   IKKα↑, 3,   IKKα↝, 1,   p‑IKKα↓, 1,   IR↓, 1,   IκB↑, 1,   p‑IκB↓, 1,   JAK↓, 3,   JAK1↓, 1,   JAK2↓, 3,   JNK↓, 30,   JNK↑, 111,   JNK↝, 3,   p‑JNK↓, 15,   p‑JNK↑, 24,   p‑JNK↝, 1,   cl‑JNK↑, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 16,   MAPK↑, 20,   MAPK↝, 1,   p‑MAPK↓, 1,   p‑MAPK↑, 5,   MEK↓, 2,   MEK↑, 1,   p‑MEK↓, 1,   MKP1↓, 1,   MKP2↓, 1,   mTOR↓, 24,   mTOR↝, 1,   p70S6↓, 1,   p‑p70S6↓, 1,   p‑p70S6↑, 1,   P70S6K↓, 4,   PAK↓, 1,   PHKG1↑, 1,   PI3K↓, 42,   PI3K↑, 1,   PI3K↝, 2,   p‑PI3K↓, 3,   PIK3CA↓, 1,   p‑PIK3R1↓, 1,   PKCδ↓, 7,   p‑PKCδ↓, 1,   PPP2R1A↑, 1,   PTEN↓, 1,   PTEN↑, 8,   PTEN↝, 1,   Raf↓, 2,   c-Raf↓, 1,   RAS↓, 3,   RIP1↓, 2,   Sp1/3/4↓, 6,   Src↓, 1,   p‑Src↓, 1,   STAT↓, 3,   STAT3↓, 26,   STAT3↑, 1,   p‑STAT3↓, 3,   STAT4↓, 1,   STAT5↓, 1,   p‑STAT6↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF3↓, 1,   ATF4↑, 3,   CBP↓, 1,   cJun↓, 4,   cJun↑, 3,   p‑cJun↓, 1,   p‑cJun↑, 1,   cMyc↓, 9,   p‑cMyc↑, 1,   DNMT1↓, 2,   DNMTs↓, 1,   EZH2↓, 1,   FOXM1↓, 2,   FOXO↑, 3,   FOXO1↓, 1,   FOXO3↓, 1,   FOXO3↑, 3,   FOXO4↑, 1,   H3↓, 2,   H3↑, 1,   H3K4↓, 1,   H3K9↓, 1,   H4↓, 1,   H4↑, 2,   HATs↓, 2,   HATs↑, 1,   HDAC↓, 5,   HDAC1↓, 1,   HDAC2↓, 1,   HMTs↓, 3,   miR-124-3p↓, 1,   miR-133a-3p↑, 1,   miR-218↑, 1,   Myc↓, 1,   Myc↑, 1,   MYCN↓, 1,   OCT4↓, 5,   other?, 1,   other↓, 3,   other↑, 2,   other↝, 2,   SOX2↓, 3,   SOX4↓, 2,   SOX9↓, 1,   SOX9↑, 1,   SUV39H↓, 1,   tumCV↓, 21,   tumCV↑, 1,   tumCV∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   cl‑ATF6↑, 1,   CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 16,   cl‑CHOP/DDIT3↑, 1,   eIF2α↓, 1,   eIF2α↑, 5,   p‑eIF2α↓, 3,   p‑eIF2α↑, 2,   ER Stress↓, 2,   ER Stress↑, 32,   GRP78/BiP↓, 3,   GRP78/BiP↑, 7,   GRP94↑, 1,   HSP27↓, 2,   HSP27↑, 1,   HSP70/HSPA5↓, 2,   HSP90↓, 5,   HSPs↓, 2,   HSPs↑, 1,   IRE1↑, 4,   p‑IRE1↓, 1,   p‑IRE1↑, 1,   PERK↑, 5,   p‑PERK↓, 1,   UPR↑, 7,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 5,   ATG7↑, 3,   Beclin-1/ATG6↑, 11,   LC3B-II↑, 1,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 8,   p62↓, 1,   p62↑, 1,   SESN2↑, 1,   TumAuto↑, 23,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 3,   p‑ATM↑, 2,   BRCA1↑, 1,   p‑BRCA1↑, 1,   BRCA2↑, 1,   DNAdam↓, 1,   DNAdam↑, 22,   DNArepair↓, 1,   DNArepair↑, 1,   hTERT/TERT↓, 2,   p16↑, 2,   P53↓, 2,   P53↑, 34,   P53↝, 1,   p‑P53↑, 2,   PARP↓, 2,   PARP↑, 8,   cl‑PARP↓, 1,   cl‑PARP↑, 34,   cl‑PARP1↑, 1,   PCNA↓, 11,   SAPK↑, 1,   Telomerase↓, 5,   TOP1↓, 3,   TOP2↓, 3,   UHRF1↓, 1,   γH2AX↑, 3,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 10,   CDK1↑, 1,   p‑CDK1↓, 1,   CDK2↓, 17,   CDK4↓, 17,   p‑CDK4↓, 1,   CDK6↓, 7,   CDK6↑, 2,   Cyc↓, 1,   Cyc↝, 1,   cycA1/CCNA1↓, 2,   CycB/CCNB1↓, 11,   CycB/CCNB1↑, 1,   cycD1/CCND1↓, 24,   cycD1/CCND1↑, 2,   cycD1/CCND1↝, 1,   p‑cycD1/CCND1↓, 1,   cycE/CCNE↓, 8,   E2Fs↓, 2,   Ki-67↓, 9,   mitA↑, 1,   P21?, 1,   P21↓, 2,   P21↑, 31,   P21↝, 1,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 12,   pRB↑, 1,   p‑pRB↓, 1,   p‑RB1↓, 2,   TumCCA↓, 1,   TumCCA↑, 70,   WEE1↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 2,   ALDH1A1↓, 1,   CD133↓, 2,   CD24↓, 1,   CD34↓, 2,   cFos↓, 3,   cFos↑, 1,   p‑cFos↓, 1,   CSCs↓, 12,   Diff↓, 1,   FGF↓, 1,   Gli1↓, 2,   HH↓, 2,   IGF-1↓, 2,   IGFBP3↑, 2,   Jun↓, 1,   Ki-67↓, 9,   mTORC1↓, 3,   Nanog↓, 5,   Nestin↓, 1,   NICD↓, 1,   NOTCH↓, 4,   NOTCH1↓, 6,   NOTCH3↓, 3,   p300↓, 1,   Shh↓, 1,   Smo↓, 1,   STAT1↓, 1,   TAZ↓, 1,   TumCG↓, 28,   TumCG↑, 1,   TumCP↓, 50,   TumCP↑, 1,   TumCP∅, 1,   Wnt↓, 13,   Wnt/(β-catenin)↓, 2,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg↑, 2,   AP-1↓, 9,   AP-1↑, 1,   AP-1↝, 1,   ATPase↓, 1,   AXL↓, 3,   Ca+2↓, 1,   Ca+2↑, 20,   i-Ca+2?, 1,   mt-Ca+2↑, 1,   CAFs/TAFs↓, 1,   cal2↓, 1,   cal2↑, 1,   CCN2/CTGF↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   DLC1↑, 1,   E-cadherin↓, 2,   E-cadherin↑, 8,   EMMPRIN↓, 1,   EMT↓, 20,   EMT↝, 1,   F-actin↓, 1,   FAK↓, 12,   fascin↓, 1,   ITGA5↓, 1,   ITGB1↓, 1,   ITGB4↓, 1,   LAMs↓, 1,   MALAT1↓, 2,   MET↓, 2,   p‑MET↓, 1,   MMP-10↓, 1,   MMP1↓, 2,   MMP13↓, 2,   MMP2↓, 23,   MMP2↝, 1,   MMP3↓, 1,   MMP7↓, 4,   MMP9↓, 38,   MMPs↓, 10,   MUC1↓, 1,   MUC4↓, 1,   N-cadherin↓, 8,   PDGF↓, 3,   Rac1↓, 1,   Rho↓, 2,   ROCK1↑, 1,   Slug↓, 2,   Smad1↝, 1,   Snail?, 1,   Snail↓, 2,   TET1↑, 1,   TGF-β↓, 7,   TGF-β↑, 1,   TGF-β↝, 1,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP1↑, 4,   TIMP2↓, 2,   TIMP2↑, 5,   TRIB3↑, 1,   TumCI↓, 23,   TumCMig↓, 22,   TumMeta↓, 22,   TumMeta↑, 1,   TumPF↓, 1,   Twist↓, 4,   Tyro3↓, 1,   uPA↓, 10,   uPAR↓, 1,   Vim↓, 6,   Vim↑, 1,   Zeb1↓, 3,   ZEB2↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 16,   β-catenin/ZEB1↑, 1,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 22,   angioG↑, 1,   CD31/PECAM-1↓, 2,   eNOS↓, 1,   HIF-1↓, 2,   Hif1a↓, 17,   Hif1a↑, 3,   NO↓, 3,   NO↑, 2,   VEGF↓, 35,   VEGF↝, 1,   VEGFR2/KDR/Flk1↓, 8,  

Barriers & Transport(tgid=15) ⓘ

CLDN1↓, 1,   GLUT1↓, 3,   GLUT1↑, 1,   GLUT3↑, 1,   GLUT4↓, 2,   MMP↓, 47,   MMP↑, 1,   MPT↑, 1,   TRPM7↓, 2,   TRPV1↑, 2,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   CD44↓, 4,   CD47↓, 1,   CD8+↑, 2,   p‑cDC2↓, 1,   COX2/PTGS2↓, 27,   COX2/PTGS2↝, 1,   CXCL1↓, 1,   CXCR4↓, 7,   DR4↑, 4,   FOXP3↓, 1,   FOXP3↑, 1,   ICAM-1↓, 2,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 2,   IL10↓, 1,   IL10↑, 1,   IL12↓, 2,   IL18↓, 1,   IL1β↓, 4,   IL2↓, 2,   IL2↑, 2,   IL4↓, 2,   IL4↑, 1,   IL5↓, 1,   IL6↓, 13,   IL6↑, 1,   IL6↝, 1,   IL8↓, 5,   Imm↑, 3,   Imm↝, 2,   Inflam↓, 15,   M2 MC↓, 2,   MCP1/CCL2↓, 2,   NF-kB↓, 59,   NF-kB↑, 1,   NF-kB↝, 3,   p‑NF-kB↑, 2,   NK cell↑, 2,   NLRP3↓, 2,   NLRP3↑, 1,   p65↓, 6,   p‑p65↓, 1,   PD-1↓, 1,   PD-L1↓, 2,   PD-L1↑, 1,   PGE2↓, 7,   PSA↓, 2,   PSA↝, 1,   RAGE↓, 1,   T-Cell↑, 3,   Th1 response↑, 1,   TLR1↑, 1,   TLR2↑, 1,   TLR4↑, 1,   TLR4↝, 1,   TNF-α↓, 11,   TNF-α↑, 3,   TNF-α↝, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 8,   AR↝, 1,   ER-α36↓, 1,   ER(estro)↓, 1,   cl‑PPARα↓, 1,   PPARγ↓, 1,   PPARγ↑, 3,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 9,   BioAv↑, 18,   BioAv↝, 2,   chemoR↓, 1,   ChemoSen↓, 1,   ChemoSen↑, 48,   CompStab↓, 2,   CompStab↑, 1,   CompStab↝, 1,   CYP1A1↓, 3,   CYP1A2↓, 1,   CYP1B1↑, 1,   Dose?, 1,   Dose↝, 23,   Dose∅, 2,   eff↓, 33,   eff↑, 32,   eff↝, 4,   eff∅, 1,   Half-Life↓, 6,   Half-Life↑, 2,   Half-Life↝, 5,   MDR1↓, 3,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 6,   P-gp/ABCB1↑, 1,   P450↓, 1,   RadioS↑, 17,   selectivity?, 2,   selectivity↑, 32,   selectivity∅, 1,   Synergy↑, 32,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   AR↓, 8,   AR↝, 1,   BMD↑, 1,   BRCA1↑, 1,   p‑BRCA1↑, 1,   CEA↓, 1,   EGFR↓, 11,   EGFR↑, 1,   EGFR↝, 1,   p‑EGFR↓, 1,   EZH2↓, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 4,   hTERT/TERT↓, 2,   IL6↓, 13,   IL6↑, 1,   IL6↝, 1,   LDH↓, 2,   LDH↑, 2,   Myc↓, 1,   Myc↑, 1,   NSE↓, 1,   PD-L1↓, 2,   PD-L1↑, 1,   PSA↓, 2,   PSA↝, 1,   RAGE↓, 1,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 12,   antiNeop↑, 1,   AntiTum↑, 7,   cachexia↓, 1,   cardioP↑, 1,   chemoP↑, 11,   chemoPv↑, 10,   ChemoSideEff↓, 2,   cognitive?, 1,   cognitive↑, 2,   hepatoP↑, 4,   neuroP↑, 6,   NP/CIPN↓, 1,   OS↑, 4,   PFS↑, 1,   QoL↑, 2,   radioP↑, 5,   RenoP↑, 2,   Risk↓, 3,   toxicity?, 1,   toxicity↓, 2,   toxicity∅, 1,   TumVol↓, 8,   TumW↓, 5,   Weight↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 1,   Bacteria↓, 1,   Diar↓, 1,   GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 2,  
Total Targets: 752

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 34,   ARE↑, 2,   Bil↑, 1,   Catalase↓, 1,   Catalase↑, 24,   Fenton↓, 1,   GCLC↑, 2,   GCLM↑, 2,   GPx↑, 16,   GPx1↑, 1,   GPx4↑, 4,   GSH↑, 23,   GSR↓, 1,   GSR↑, 2,   GSTs↓, 1,   GSTs↑, 6,   H2O2↓, 1,   H2O2↑, 1,   HDL↑, 1,   HO-1↓, 1,   HO-1↑, 16,   Iron↓, 1,   i-Iron↓, 1,   Keap1↓, 2,   lipid-P↓, 15,   MDA↓, 18,   MPO↓, 4,   NOX↓, 1,   NQO1↑, 2,   NRF2↓, 1,   NRF2↑, 26,   RNS↓, 1,   ROS↓, 51,   ROS↑, 2,   ROS∅, 1,   SOD↓, 1,   SOD↑, 30,   SOD1↑, 2,   SOD2↑, 1,   TBARS↓, 1,   Trx1↑, 1,   VitC↑, 2,   VitE↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↑, 1,   IronCh↑, 2,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   Insulin↑, 1,   mtDam↓, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   15-LOX/ALOX15↓, 1,   5LO↓, 2,   ACSL4↓, 1,   adiP↑, 1,   ALAT↓, 6,   AMPK↑, 8,   p‑AMPK↑, 1,   ATP↑, 1,   cAMP↑, 2,   FABP4↓, 1,   glucose↓, 1,   glucose↝, 2,   GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   H2S↑, 1,   HMG-CoA↓, 1,   LDL↓, 1,   NADPH↓, 2,   SIRT1↑, 2,   SIRT1∅, 1,  

Cell Death(tgid=5) ⓘ

APAF1↓, 1,   Apoptosis↓, 10,   ASK1↓, 1,   BAX↓, 7,   BAX↑, 1,   Bax:Bcl2↝, 1,   Bcl-2↓, 1,   Bcl-2↑, 5,   Casp↓, 1,   Casp12↓, 2,   Casp3↓, 9,   Casp3∅, 2,   cl‑Casp3↓, 1,   Casp6↓, 1,   Casp9↓, 7,   Casp9∅, 1,   Cyt‑c↓, 2,   Cyt‑c∅, 2,   Fas↓, 1,   Ferroptosis↓, 5,   GranB/GZMB↓, 1,   GRP58↓, 1,   iNOS↓, 13,   iNOS↑, 3,   necrosis↓, 1,   p38↓, 12,   p‑p38↓, 8,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 5,   Akt↝, 1,   p‑Akt↑, 2,   CREB↑, 1,   ERK↓, 9,   ERK↑, 5,   p‑ERK↓, 4,   p‑ERK↑, 3,   HGF/c-Met↑, 1,   p‑IKKα↓, 2,   p‑IκB↓, 1,   JNK↓, 30,   JNK↑, 4,   p‑JNK↓, 14,   p‑JNK↑, 4,   MAPK↓, 13,   MAPK↑, 1,   MAPK↝, 1,   p‑MAPK↓, 2,   MEK↓, 1,   p‑MKK4↑, 1,   Mst1↓, 1,   mTOR↓, 1,   mTOR↑, 2,   p‑P70S6K↑, 1,   PI3K↓, 1,   PI3K↑, 2,   p‑PI3K↑, 1,   PKCδ↓, 1,   STAT3↝, 1,   STAT4↓, 1,   STAT5↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,   ATF4↓, 1,   p‑cJun↓, 1,   cMyc↓, 1,   p‑cMyc↑, 1,   FOXO↑, 1,   FOXO3↑, 1,   HDAC↓, 1,   other↓, 1,   other↑, 4,   other↝, 7,   RUNX2∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 3,   CHOP/DDIT3↑, 2,   p‑eIF2α↓, 1,   cl‑eIF2α↑, 1,   ER Stress↓, 7,   GRP78/BiP↓, 6,   GRP78/BiP↑, 2,   GRP94↑, 1,   HSP70/HSPA5↑, 2,   HSPs↑, 1,   IRE1↓, 3,   p‑PERK↑, 1,   UPR↓, 1,   XBP-1↓, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↑, 2,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B↑, 1,   LC3II↑, 1,   p62↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

P53↓, 3,   PARP∅, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↓, 1,   neuroG↑, 1,   STAT1↓, 1,   TumCP↓, 2,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 4,   ARG1/2↑, 1,   Ca+2↓, 2,   Ca+2↝, 1,   COL1∅, 1,   EMT↑, 1,   heparanase↑, 1,   MMP1↓, 1,   MMP13↓, 1,   MMP2↓, 1,   MMP3↓, 1,   MMP9↓, 5,   TGF-β↓, 1,   TGF-β↑, 2,   TGF-β1↑, 1,   TumCI↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   E-sel↓, 2,   Hif1a↓, 1,   NO↓, 10,   NO↑, 1,   TXA2↓, 1,   VCAM-1↓, 4,   VEGF↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB?, 1,   BBB↑, 6,   BBB↝, 1,   BBB∅, 2,   CLDN4↑, 1,   GLUT2↑, 1,   IBI↑, 1,   MMP↓, 1,   MMP↑, 7,   MMP∅, 1,   MUC19↓, 1,   MUC2↓, 1,   MUC5AC↓, 1,   OCLN↑, 1,   TJ↑, 2,   TRPC1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

AIF1/Iba-1↓, 1,   CB2 / CNR2↑, 1,   CCL11↓, 1,   CD4+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 19,   CXCR4↓, 1,   HMGB1↓, 1,   ICAM-1↓, 4,   IFN-γ↓, 3,   IL1↓, 2,   IL10↑, 5,   IL12↓, 1,   IL17↓, 2,   IL18↓, 2,   IL1β↓, 21,   IL4↓, 3,   IL4↑, 1,   IL6↓, 24,   IL8↓, 3,   Imm↑, 5,   Inflam?, 1,   Inflam↓, 51,   IRF3↓, 1,   LPS↓, 1,   Macrophages↓, 1,   MCP1/CCL2↓, 1,   MyD88↓, 2,   NeuroI↓, 1,   Neut↓, 1,   NF-kB↓, 31,   p‑NF-kB↓, 2,   NLRP3↓, 6,   p65↓, 1,   p‑p65↓, 1,   PGE2↓, 5,   PGE2↑, 1,   RAGE↓, 1,   Th1 response↓, 2,   Th17↓, 1,   Th2↑, 2,   TLR2↓, 1,   TLR4↓, 7,   TLR4∅, 1,   TNF-α↓, 31,   TRIF↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 8,   BChE↓, 2,   BDNF↑, 7,   BDNF∅, 1,   ChAT↑, 1,   NGF↑, 1,   PSD95↑, 2,   SNAP25↑, 2,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 1,   Aβ↓, 11,   Aβ42↓, 1,   BACE/β-secretase↓, 2,   tau↓, 2,   p‑tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ER(estro)↑, 1,   GR↑, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 1,   p‑PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 12,   BioAv↑, 7,   BioAv↝, 9,   Dose?, 1,   Dose↑, 2,   Dose⇅, 1,   Dose↝, 6,   eff↑, 7,   eff↝, 1,   GSTA1↑, 2,   Half-Life↝, 5,   P450↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 6,   ALP↓, 2,   ALP∅, 1,   AST↓, 6,   BG↓, 2,   Bil↑, 1,   BP↓, 4,   creat↓, 1,   CRP↓, 3,   IL6↓, 24,   LDH↓, 3,   LDH↑, 1,   OCN∅, 1,   RAGE↓, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 3,   antiAll↑, 5,   AntiArt↑, 3,   AntiCan↑, 4,   AntiDiabetic↓, 1,   AntiDiabetic↑, 4,   antiPs↑, 1,   AntiTum↑, 1,   cardioP↑, 12,   CardioT↓, 1,   chemoP↑, 2,   chemoPv↑, 1,   cognitive↑, 15,   diuretic↑, 1,   hepatoP↓, 1,   hepatoP↑, 16,   Learn↑, 2,   memory↑, 13,   motorD↓, 1,   motorD↑, 2,   neuroP↑, 37,   Obesity↓, 1,   Pain↓, 2,   radioP↑, 4,   RenoP↑, 5,   Strength↑, 1,   Stroke↓, 4,   toxicity?, 1,   toxicity↓, 10,   toxicity↝, 2,   toxicity∅, 2,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 4,   Bacteria↓, 7,   Diar↓, 1,   GutMicro↑, 5,   Inf↓, 1,   Sepsis↓, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 351

Scientific Paper Hit Count for: JNK, c-Jun N-terminal kinase (JNK)
9 Berberine
9 Curcumin
9 Luteolin
7 Fisetin
7 Silymarin (Milk Thistle) silibinin
6 Apigenin (mainly Parsley)
6 Shikonin
6 Thymoquinone
5 Silver-NanoParticles
5 Allicin (mainly Garlic)
5 Capsaicin
5 Rosmarinic acid
4 Alpha-Lipoic-Acid
4 Baicalein
4 Chlorogenic acid
4 Chrysin
4 Copper and Cu NanoParticles
4 Disulfiram
4 Gambogic Acid
4 Kaempferol
4 Licochalcone A
4 Magnolol
4 Magnetic Fields
4 Piperlongumine
3 Radiotherapy/Radiation
3 Cisplatin
3 Artemisinin
3 Betulinic acid
3 Benzyl isothiocyanate
3 Carvacrol
3 chaetocin
3 EGCG (Epigallocatechin Gallate)
3 Hydrogen Gas
3 isoorientin
3 Lycopene
3 Melatonin
3 Propolis -bee glue
3 Phenethyl isothiocyanate
3 Quercetin
2 Astragalus
2 Vitamin C (Ascorbic Acid)
2 Ashwagandha(Withaferin A)
2 Beta-Caryophyllene
2 Boswellia (frankincense)
2 brusatol
2 Thymol-Thymus vulgaris
2 Celastrol
2 Ursolic acid
2 Ferulic acid
2 Ginger/6-Shogaol/Gingerol
2 Hibiscus sabdariffa
2 Juglone
2 Magnetic Field Rotating
2 Phenylbutyrate
2 Plumbagin
2 Resveratrol
2 Vitamin K2
1 1,8-Cineole
1 3-bromopyruvate
1 Camptothecin
1 Allyl isothiocyanate
1 Anethole/trans-Anethole
1 Berbamine
1 Bromelain
1 Black Rice, Oryza sativa
1 Bruteridin(bergamot juice)
1 α-Bisabolol / Chamomile oil
1 Caffeic acid
1 Crocetin
1 Cucurbitacin
1 Bicalutamide
1 Sulforaphane (mainly Broccoli)
1 Dihydrocaffeic Acid
1 Cynaropicrin
1 Dandelion Root
1 Emodin
1 Eugenol
1 5-fluorouracil
1 Evodiamine
1 Ascorbyl Palmitate
1 Garcinol
1 Ginkgo biloba
1 Genistein (soy isoflavone)
1 Ginkgolide B
1 Ginkgetin
1 Graviola
1 Honokiol
1 HydroxyTyrosol
1 Hyperoside
1 Indole-3-carbinol
1 Isoliquiritigenin
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 Linalool
1 Matrine
1 Morin
1 Methylsulfonylmethane
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Niclosamide (Niclocide)
1 Patchouli Oil (Pogostemon cablin)
1 SonoDynamic Therapy UltraSound
1 Hyperthermia
1 Phycocyanin
1 Parthenolide
1 Pterostilbene
1 Perilla
1 Rutin
1 buckwheat sprouts
1 salinomycin
1 Gemcitabine (Gemzar)
1 Salvia miltiorrhiza
1 Aflavin-3,3′-digallate
1 Vitexin
1 Zyflamend
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:168  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page